We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA: Drugmakers Don’t Scrutinize Data Integrity in Supplier Audits
FDA: Drugmakers Don’t Scrutinize Data Integrity in Supplier Audits
FDA investigators are finding unprecedented data integrity problems at contract and active pharmaceutical ingredient manufacturers, even after they have been audited by the firms that hired them, an FDA official said.